Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Meetings, Planning & Dissemination Grant: Cancer Research

Université de Montréal

$16,920.00

Technological Advances in RNA Therapy Symposium

FY 2010-11

Summary
In the recent years, the discovery that gene expression is controlled by small guide RNAs has reopened the hopes of using RNAs as therapeutics of cancer and other diseases. Through major breakthroughs in several molecular biology and high-throughput techniques, the role of small RNAs in gene expression and various signaling pathways during development and carcinogenesis has been extensively studied. Hosted by the Université de Montréal's Institute for Research in Immunology and Cancer, this symposium will give an opportunity for leading scientists in the field to share recent findings about the molecular mechanisms and recent technologies for delivering RNA-based therapeutics. The symposium will have three themes: 1) RNA Synthetic Biology; 2) Riboswitches and Aptamers; and, 3) RNAi and microRNAs. An important fraction of the symposium will be dedicated to the presentation of new findings in these three areas. This two-day event will bring together locally, nationally, as well as internationally recognized researchers, postdoctoral fellows, graduate students and other members of the academic, private and governmental sectors who share a common interest in developing new approaches to understand the role of RNAs in gene expression and problems underlying cancer and its immunological aspects. Seminars will be given by 16 high profile Canadian and International invited scientists. A visit of the Institute, welcome dinner, and the coffee breaks and lunches with the guest speakers will promote interactions and networking among the participants. The Technological Advances in RNA Therapy Symposium will be a unique opportunity to promote discussions about what the pharmaceutical industry calls the "next generation drugs", that is the coming ones that will be based on RNA therapeutics.
Program
Meetings, Planning & Dissemination Grant: Cancer Research
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
228058
Name
Major François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Meetings, Planning and Dissemination Grant: ICR
Projecttitle
Technological Advances in RNA Therapy Symposium
Programtype2
Miscellaneous Programs
Orgnameinp2
Université de Montréal
Cihramount2
$16,920
Cihrequipment2
$0
Programname2
Meetings, Planning & Dissemination Grant: Cancer Research
Keyworddelim
Cancer; Rna; Small Rnas; Synthetic Biology; Therapy
Abstract
In the recent years, the discovery that gene expression is controlled by small guide RNAs has reopened the hopes of using RNAs as therapeutics of cancer and other diseases. Through major breakthroughs in several molecular biology and high-throughput techniques, the role of small RNAs in gene expression and various signaling pathways during development and carcinogenesis has been extensively studied. Hosted by the Université de Montréal's Institute for Research in Immunology and Cancer, this symposium will give an opportunity for leading scientists in the field to share recent findings about the molecular mechanisms and recent technologies for delivering RNA-based therapeutics. The symposium will have three themes: 1) RNA Synthetic Biology; 2) Riboswitches and Aptamers; and, 3) RNAi and microRNAs. An important fraction of the symposium will be dedicated to the presentation of new findings in these three areas. This two-day event will bring together locally, nationally, as well as internationally recognized researchers, postdoctoral fellows, graduate students and other members of the academic, private and governmental sectors who share a common interest in developing new approaches to understand the role of RNAs in gene expression and problems underlying cancer and its immunological aspects. Seminars will be given by 16 high profile Canadian and International invited scientists. A visit of the Institute, welcome dinner, and the coffee breaks and lunches with the guest speakers will promote interactions and networking among the participants. The Technological Advances in RNA Therapy Symposium will be a unique opportunity to promote discussions about what the pharmaceutical industry calls the "next generation drugs", that is the coming ones that will be based on RNA therapeutics.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Major, François
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $16,920~ $0~